Other Species / Isoforms
  SEC22B (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T5-p
___MVLLtMIARVAD
0 1
SEC22B (human) ___MVLLtMIARVAD T5-p
SEC22B (mouse) ___MVLLTMIARVAD T5
SEC22B (rat) ___MVLLTMIARVAD T5
S19-p
DGLPLAAsMQEDEQs
0 1
SEC22B (human) DGLPLAAsMQEDEQs S19-p
SEC22B (mouse) DGLPLAASMQEDEQS S19
SEC22B (rat) DGLPLAASMQEDEQS S19
S26-p
sMQEDEQsGRDLQQy
0 2
SEC22B (human) sMQEDEQsGRDLQQy S26-p
SEC22B (mouse) SMQEDEQSGRDLQQY S26
SEC22B (rat) SMQEDEQSGRDLQQY S26
Y33-p
sGRDLQQyQsQAkQL
0 2
SEC22B (human) sGRDLQQyQsQAkQL Y33-p
SEC22B (mouse) SGRDLQQYQsQAkQL Y33
SEC22B (rat) SGRDLQQYQSQAkQL Y33
S35-p
RDLQQyQsQAkQLFR
Upstream
0 9
Treatment
  • metformin
SEC22B (human) RDLQQyQsQAkQLFR S35-p
SEC22B (mouse) RDLQQYQsQAkQLFR S35-p
SEC22B (rat) RDLQQYQSQAkQLFR S35
K38-ac
QQyQsQAkQLFRkLN
0 5
SEC22B (human) QQyQsQAkQLFRkLN K38-ac
SEC22B (mouse) QQYQsQAkQLFRKLN K38-ac
SEC22B (rat) QQYQSQAkQLFRKLN K38-ac
K38-ub
QQyQsQAkQLFRkLN
0 17
SEC22B (human) QQyQsQAkQLFRkLN K38-ub
SEC22B (mouse) QQYQsQAkQLFRKLN K38-ub
SEC22B (rat) QQYQSQAKQLFRKLN K38
K38-sc
QQyQsQAkQLFRkLN
0 1
SEC22B (human) QQyQsQAkQLFRkLN K38-sc
SEC22B (mouse) QQYQsQAkQLFRKLN K38-sc
SEC22B (rat) QQYQSQAKQLFRKLN K38
K43-ac
QAkQLFRkLNEQsPt
0 9
SEC22B (human) QAkQLFRkLNEQsPt K43-ac
SEC22B (mouse) QAkQLFRKLNEQSPt K43
SEC22B (rat) QAkQLFRKLNEQSPT K43
S48-p
FRkLNEQsPtRCTLE
0 2
SEC22B (human) FRkLNEQsPtRCTLE S48-p
SEC22B (mouse) FRKLNEQSPtRCTLE S48
SEC22B (rat) FRKLNEQSPTRCTLE S48
T50-p
kLNEQsPtRCTLEAG
0 2
SEC22B (human) kLNEQsPtRCTLEAG T50-p
SEC22B (mouse) KLNEQSPtRCTLEAG T50-p
SEC22B (rat) KLNEQSPTRCTLEAG T50
K82-ub
CEAAFPKkLAFAYLE
0 20
SEC22B (human) CEAAFPKkLAFAYLE K82-ub
SEC22B (mouse) CEAAFPKkLAFAYLE K82-ub
SEC22B (rat) CEAAFPKKLAFAYLE K82
K82-sm
CEAAFPKkLAFAYLE
0 1
SEC22B (human) CEAAFPKkLAFAYLE K82-sm
SEC22B (mouse) CEAAFPKKLAFAYLE K82
SEC22B (rat) CEAAFPKKLAFAYLE K82
S93-p
AYLEDLHsEFDEQHG
0 1
SEC22B (human) AYLEDLHsEFDEQHG S93-p
SEC22B (mouse) AYLEDLHSEFDEQHG S93
SEC22B (rat) AYLEDLHSEFDEQHG S93
K101
EFDEQHGKkVPTVsR
0 1
SEC22B (human) EFDEQHGKkVPTVsR K101
SEC22B (mouse) EFDEQHGkkVPTVSR K101-ub
SEC22B (rat) EFDEQHGKKVPTVSR K101
K102-ub
FDEQHGKkVPTVsRP
0 3
SEC22B (human) FDEQHGKkVPTVsRP K102-ub
SEC22B (mouse) FDEQHGkkVPTVSRP K102-ub
SEC22B (rat) FDEQHGKKVPTVSRP K102
S107-p
GKkVPTVsRPysFIE
0 1
SEC22B (human) GKkVPTVsRPysFIE S107-p
SEC22B (mouse) GkkVPTVSRPYSFIE S107
SEC22B (rat) GKKVPTVSRPYSFIE S107
Y110-p
VPTVsRPysFIEFDT
0 1
SEC22B (human) VPTVsRPysFIEFDT Y110-p
SEC22B (mouse) VPTVSRPYSFIEFDT Y110
SEC22B (rat) VPTVSRPYSFIEFDT Y110
S111-p
PTVsRPysFIEFDTF
0 3
SEC22B (human) PTVsRPysFIEFDTF S111-p
SEC22B (mouse) PTVSRPYSFIEFDTF S111
SEC22B (rat) PTVSRPYSFIEFDTF S111
K121-ub
EFDTFIQkTKKLYID
0 2
SEC22B (human) EFDTFIQkTKKLYID K121-ub
SEC22B (mouse) EFDTFIQKTKKLYID K121
SEC22B (rat) EFDTFIQKTKKLYID K121
S137-p
RARRNLGsINtELQD
Upstream
0 81
Treatment
  • angiotensin_2
  • antibody
  • EGF
  • ischemia
  • metastatic potential
  • SB202190
  • SII_angiotensin_2
  • U0126
SEC22B (human) RARRNLGsINtELQD S137-p
SEC22B (mouse) RARRNLGsINtELQD S137-p
SEC22B (rat) RARRNLGsINTELQD S137-p
T140-p
RNLGsINtELQDVQR
0 9
SEC22B (human) RNLGsINtELQDVQR T140-p
SEC22B (mouse) RNLGsINtELQDVQR T140-p
SEC22B (rat) RNLGsINTELQDVQR T140
S164-p
LQRGEALsALDskAN
0 7
SEC22B (human) LQRGEALsALDskAN S164-p
SEC22B (mouse) LQRGEALsALDskAN S164-p
SEC22B (rat) LQRGEALSALDsKAN S164
S168-p
EALsALDskANNLss
Upstream
0 20
Treatment
  • ischemia
  • metformin
SEC22B (human) EALsALDskANNLss S168-p
SEC22B (mouse) EALsALDskANNLSs S168-p
SEC22B (rat) EALSALDsKANNLSS S168-p
K169-ub
ALsALDskANNLssL
0 29
SEC22B (human) ALsALDskANNLssL K169-ub
SEC22B (mouse) ALsALDskANNLSsL K169-ub
SEC22B (rat) ALSALDsKANNLSSL K169
S174-p
DskANNLssLskkYR
0 4
SEC22B (human) DskANNLssLskkYR S174-p
SEC22B (mouse) DskANNLSsLsKKYR S174
SEC22B (rat) DsKANNLSSLsKKYR S174
S175-p
skANNLssLskkYRQ
0 12
SEC22B (human) skANNLssLskkYRQ S175-p
SEC22B (mouse) skANNLSsLsKKYRQ S175-p
SEC22B (rat) sKANNLSSLsKKYRQ S175
S177-p
ANNLssLskkYRQDA
0 18
SEC22B (human) ANNLssLskkYRQDA S177-p
SEC22B (mouse) ANNLSsLsKKYRQDA S177-p
SEC22B (rat) ANNLSSLsKKYRQDA S177-p
K178-ub
NNLssLskkYRQDAk
0 3
SEC22B (human) NNLssLskkYRQDAk K178-ub
SEC22B (mouse) NNLSsLsKKYRQDAK K178
SEC22B (rat) NNLSSLsKKYRQDAK K178
K178-sc
NNLssLskkYRQDAk
0 1
SEC22B (human) NNLssLskkYRQDAk K178-sc
SEC22B (mouse) NNLSsLsKKYRQDAK K178
SEC22B (rat) NNLSSLsKKYRQDAK K178
K179-ub
NLssLskkYRQDAkY
0 1
SEC22B (human) NLssLskkYRQDAkY K179-ub
SEC22B (mouse) NLSsLsKKYRQDAKY K179
SEC22B (rat) NLSSLsKKYRQDAKY K179
K185-ub
kkYRQDAkYLNMRSt
0 1
SEC22B (human) kkYRQDAkYLNMRSt K185-ub
SEC22B (mouse) KKYRQDAKYLNMRST K185
SEC22B (rat) KKYRQDAKYLNMRST K185
T192-p
kYLNMRStyAKLAAV
0 1
SEC22B (human) kYLNMRStyAKLAAV T192-p
SEC22B (mouse) KYLNMRSTYAKLAAV T192
SEC22B (rat) KYLNMRSTYAKLAAV T192
Y193-p
YLNMRStyAKLAAVA
0 1
SEC22B (human) YLNMRStyAKLAAVA Y193-p
SEC22B (mouse) YLNMRSTYAKLAAVA Y193
SEC22B (rat) YLNMRSTYAKLAAVA Y193